CM Management’s OS Therapies Inc OSTX Stock Holding History

CM Management’s Portfolio OSTX Stock Details OSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$564K	Hold	400,000	–	–	0.47%	61
2025 Q4	$560K	Hold	400,000	–	–	0.47%	51
2025 Q3	$784K	Buy	400,000 +25,000	+7%	+$49.5K	0.65%	53
2025 Q2	$705K	Buy	375,000 +75,000	+25%	+$126K	0.64%	48
2025 Q1	$462K	Buy	300,000 +189,956	+173%	+$446K	0.46%	47
2024 Q4	$471K	Buy	110,044 +60,044	+120%	+$176K	0.42%	49
2024 Q3	$140K	Buy	+50,000	New	+$179K	0.11%	63

Other funds holding OSTX

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HFS

Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BPA

Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return

CM Management's OSTX Position: Q1 2026 in Review

CM Management held its OS Therapies Inc (OSTX) position steady in Q1 2026 at 400,000 shares worth $564K. The position accounts for 0.47% of the portfolio, ranked #61.

CM Management first reported a position in OSTX in Q3 2024 and has held it in 7 quarters since. The position peaked at $784K in Q3 2025. 29 funds tracked by Wall St. Rank hold OSTX as of Q1 2026.

CM Management held 400,000 shares of OS Therapies Inc worth $564K as of Q1 2026.
CM Management left its OS Therapies Inc share count unchanged in Q1 2026.
OS Therapies Inc made up 0.47% of CM Management's portfolio in Q1 2026, its #61 holding.
CM Management first reported a position in OS Therapies Inc in Q3 2024 and has held it in 7 quarters since.
CM Management's OS Therapies Inc position peaked at $784K in Q3 2025.
29 funds tracked by Wall St. Rank held OS Therapies Inc as of Q1 2026.

Based on CM Management's 13F filing for Q1 2026, filed 8 May 2026.